Navigation Links
Men Might Get Their Share of Cervical Cancer Vaccine As Well

The first ever-cervical cancer vaccine, Gardasil is expected to be launched in New Zealand soon, targeting females between 9 and 24 years of age. // Soon, men might also be given cervical cancer vaccines to prevent them from infecting their sexual partners and to protect themselves against several diseases.

The vaccine is currently under experimental phase, for demonstration of cervical cancer prevention. Most cases of cervical cancer can be attributed to human papilloma virus infection (HPV), spread through sexual contact. An association between the virus and anal cancer has also been observed, consistent with high reports of infection among gay men.

Previous vaccine trials had demonstrated the increase in antibody production against the four target HPV types, known to cause cancer and genital warts in both men and women. There could be a 70% reduction in the cervical cancer incidence if the vaccine is found to be effective in preventing HPV associated cervical cancers.

It has been found form numerous studies that 80% of the population is exposed to HPV at some point during their lifetime. A majority of this goes unnoticed, as there are no symptoms. The immune system may be effective in getting rid of the virus. A small group of people however develop persistent infections.

The effectiveness of the vaccine would be more relevant when it is administered before onset of sexual activity. Taking this fact into account, the ideal age for administration of the vaccine is considered to be 11 years. If approved for use, it can be incorporated as the last of injections on the national immunization schedule.

Cervical cancer represents a major health care burden haunting women. This may be the focus for increased clinical trials in women when compared to the poor attention given to prevention of HPV-linked cancers in men. However, large clinical trials involving men are being conducted, the results of which would
'"/>




Page: 1 2

Related medicine news :

1. Anemia Treatment for Cancer Patients Might Not be a Good Idea.
2. Tomatoes Might Inhibit the Development Of Prostate Cancer
3. Mad Cow Disease Might Be Linked to Blood Transfusions
4. Strategies That Might Lower Blood Pressure Questioned
5. Factors That Might Increase The Risk Of Schizophrenia
6. A Drug That Might Relieve Chronic Cough
7. Biochemical Markers Might Help Predict Heart Problems
8. Yoga Might Be Helpful For Cancer Patients
9. Healthcare Professionals Might Want To Rethink Their Dress Code
10. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
11. Counting Calories Might Be The Ideal Way To Stay Healthy
Post Your Comments:
(Date:12/2/2008)...Provides Online Resource and Fire Safety Tips for ... Boston, MA (PRWEB) December 2, 2008 --...ete , actress, philanthropist and mother of four, ...a few moments before the holiday rush to review fi...Smart.com. , , , , ,Home fires top the list of Am...
(Date:12/1/2008)...Patient satisfaction scores at,outpatient health ... report,from Press Ganey Associates, Inc. The 20...on American Health Care cites increased competitio... patient services. The report,includes responses... than,1,200 outpatient care facilities nationwide...
(Date:12/1/2008)...e availability of a portable eight-slice computed ...ignificantly increase the number of stroke victims...Results of the study, conducted at North Shore Med... will be presented today at the annual meeting of ... , "The hospital,s acquisition of a portable CT ...
(Date:12/1/2008)...nection between second-hand smoke and coronary hea...s passed to reduce such passive smoking, exposures... January 2009 issue of the American Journal of Pr...y of California, San Francisco, Partners Healthcar...d the CHD Policy Model to better predict future tr...
Breaking Medicine News(10 mins):Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 2Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 4Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2
...e city's health services panel Friday approved a p...fixed fine for anyone who breaches tough new anti-...rafted in to back up the teams of tobacco control ...ponsibility of enforcing the no-smoking policy. S...
... researchers have found evidence that tropical cyc... ocean circulation patterns that transport heat a...e. According to Matthew Huber, Purdue University ...ciences who led the research group, the findings s...
...Over one hundred Long Island AARP members gathered...n before the end of the 2007 Legislative Session i...ore affordable and help assure that their cell pho...heir message directly to their legislators during ...
...aken up a rather strange hobby to help her keep fi...ly revealed that she has taken to the trapeze to k...for your confidence and amazing for your body but ... do something that pushed me,' the Daily Express q...
Other Medicine News:Health News:Tropical Cyclones Play Important Role in Climate-control 2Health News:Long Island Seniors Rally for Rx Affordable Prescription Drugs and Cell Phone Protections 2
(Date:11/25/2008)...l Trial to Assess Survival of Patients Receiving L...able Hepatocellular Carcinoma , , BELLEVUE,...ology, Inc. (LSO) today announced the completion o... Light Infusion Therapy(TM) (Litx(TM)) as a treatm...), also known as hepatoma or primary liver cancer....
(Date:11/24/2008)...n, Nov. 24 Takeda Pharmaceutical C...keda Global Research & Development Center, Inc...ry Committee of the U.S. Food and Drug Administrat...tat for the treatment of hyperuricemia in patient...pproval, with one panel member abstaining. The vot...
(Date:11/24/2008)...swire-FirstCall/ -- Leaders of Schering-Plough Cor...or investors on the company,s research pipeline, h...ncludes 46 new entities in clinical trials or unde... , , "Research and development is adding st...ue our transformation," said Fred Hassan, chairman...
(Date:11/24/2008)... leadership and long-term commitment to hepatitis ...ewswire-FirstCall/ -- Schering-Plough Corporation ... boceprevir, its lead investigational oral hepatit...elopment. The company believes boceprevir has the...s protease inhibitor for treating chronic hepatiti...
Breaking Medicine Technology:Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 1ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 2ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM 28TM 29 16447 3Frito Lay Launches Low Sodium Versions of its Top Selling Snack Chips 16445 1Frito Lay Launches Low Sodium Versions of its Top Selling Snack Chips 16445 2Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 1Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 2Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 3Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 4Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 5Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 6Millennium Announces VELCADE 28R 29 28Bortezomib 29 for Injection First Quarter 2008 U S Net Sales 4507 7Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 1Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 2Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 3Its neck and neck down the long stretch for 2 stroke prevention procedures 16443 4
...il 20,2007-The U.S. Food and Drug,Administration (...sumers to the availability of audio broadcasts tha...oadcasts, commonly known as,podcasts, can be trans...ayers. , The service is part of the agency,s ongoi... concerning the safety of,marketed medications whe...
...at 160th Annual Meeting of the American,Psychiatri...re-FirstCall/ -- In adults with,major depressive d...rapy (ADT) resulted in significant improvement in ...ssion Rating Scale (MADRS),Total Score. In this si...nted here at the 160th Annual Meeting of the Ameri...
Other Medicine Technology:FDA Announces Audio Broadcasts on Emerging Drug Safety Information 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 2Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 3Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 4Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 5Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 6Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 7Six-Week Investigational Study In Adults With Major Depressive,Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole,Therapy With Antidepressants 8
For administering anesthetic agents into the posterior sub-Tenon's space 20G x 1in (.90 x 25mm)
For injecting anesthetics into the muscle cone. 23G x 1 1/2 in (.60 x 38mm)
...single plane C-arm angiography system is designed ...mance and an expansive range of diagnostic and int...y to ECG triggered. Outstanding image quality ...ynamic Flat Detector technology, high frequency X-...
...ronystagmography) is a complete vestibular diagnos...eye movements collected via electrodes. Its Window...cade, tracking and Slow Phase Velocity analyses ar...aphic comparison of results to normative data. A p...
Medicine Products: